课题基金 / 基金详情

Role of CAP in In Vivo Insulin Action

Role of CAP in In Vivo Insulin Action
CAP 在体内胰岛素作用中的作用
批准号:
6994247
负责人:
Lisa A Lesniewski
金额:
$4.4万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2006-06-30

项目摘要

项目成果

Lisa A Lesniewski的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Type 2 diabetes and the metabolic syndrome are epidemic in the US, and a hallmark of both is insulin resistance. Understanding the mechanisms of insulin action is essential in the treatment of these disorders. Recently, a signaling pathway has been identified that links insulin stimulation of its receptor to glucose transport independent of PI3K. This pathway involves the activation Cbl and its adaptor protein CAP and is known to stimulate glucose uptake in cultured adipocytes. In addition to a role in stimulating glucose uptake, the Cbl/CAP complex is involved in the proliferation and motility of macrophages. As macrophage activation and chronic inflammation have been associated with insulin resistance, this dual role of Cbl/CAP may have important consequences. The general purpose of this proposal is to examine the role of CAP in regulating in vivo insulin action. The specific aims are 1) to determine if whole body gene knockout of CAP results in alterations in insulin action, 2) to determine if CAP knockout results in an upregulation of the alternate PI3K-dependent signaling pathway, and 3) to determine if macrophage infiltration, activation and cytokine production is altered in CAP knockout mice and is related to the putative changes in insulin action.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tissue senescence and age-associated metabolic dysfunction: the role of immune cell mediated inflammation
  • 批准号:
    10585818
  • 项目类别:
  • 资助金额:
    $43.29万
  • 财政年份:
    2023
  • 负责人:
    Lisa A Lesniewski
  • 依托单位:
Role of ARF6 in atherosclerotic burden and severity
Role of ARF6 in atherosclerotic burden and severity
Role of ARF6 in atherosclerotic burden and severity
海外基金